Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shôn W Lewis

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Current Opinion in Psychiatry|April 28, 2006
Early detection of schizophreniaRichard J Drake, Shôn W Lewis
The British Journal of Psychiatry. Supplement|August 2, 2005
Integrating non-drug treatments in early schizophreniaShôn W Lewis, Nicolas Tarrier, Richard James Drake
The British Journal of Psychiatry. Supplement|August 2, 2005
Duration of untreated psychosis and its relationship to clinical outcomeRoss M G Norman, Shôn W Lewis, Max Marshall
International Journal of Psychiatry in Clinical Practice|November 30, 2011
Sexual function of patients with schizophrenia receiving first-generation (FGA) or second-generation antipsychotic (SGA) treatmentAhmed Mahmoud, Karen P Hayhurst, Richard J Drake, et al.
Schizophrenia Research and Treatment|September 1, 2012
Second generation antipsychotics improve sexual dysfunction in schizophrenia: a randomised controlled trialAhmed Mahmoud, Karen P Hayhurst, Richard J Drake, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 27, 2013
Treating impaired cognition in schizophrenia: the case for combining cognitive-enhancing drugs with cognitive remediationPanayiota G Michalopoulou, Shôn W Lewis, Til Wykes, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 24, 2012
Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugsMichael J Peluso, Shôn W Lewis, Thomas R E Barnes, et al.
Schizophrenia Research|January 15, 2013
Non-neurological and metabolic side effects in the Cost Utility of the Latest Antipsychotics in Schizophrenia Randomised Controlled Trial (CUtLASS-1)Michael J Peluso, Shôn W Lewis, Thomas R E Barnes, et al.
Psychiatry Research|July 26, 2015
Patients' subjective rating of mental health improvement in a randomised controlled trialKaren P Hayhurst, Richard J Drake, Jennifer A Massie, et al.
Plos One|May 19, 2016
Correction: Therapist Effects and the Impact of Early Therapeutic Alliance on Symptomatic Outcome in Chronic Fatigue SyndromeLucy P Goldsmith, Graham Dunn, Richard P Bentall, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Current Opinion in Psychiatry|April 28, 2006
Early detection of schizophreniaRichard J Drake, Shôn W Lewis
The British Journal of Psychiatry. Supplement|August 2, 2005
Integrating non-drug treatments in early schizophreniaShôn W Lewis, Nicolas Tarrier, Richard James Drake
The British Journal of Psychiatry. Supplement|August 2, 2005
Duration of untreated psychosis and its relationship to clinical outcomeRoss M G Norman, Shôn W Lewis, Max Marshall
International Journal of Psychiatry in Clinical Practice|November 30, 2011
Sexual function of patients with schizophrenia receiving first-generation (FGA) or second-generation antipsychotic (SGA) treatmentAhmed Mahmoud, Karen P Hayhurst, Richard J Drake, et al.
Schizophrenia Research and Treatment|September 1, 2012
Second generation antipsychotics improve sexual dysfunction in schizophrenia: a randomised controlled trialAhmed Mahmoud, Karen P Hayhurst, Richard J Drake, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 27, 2013
Treating impaired cognition in schizophrenia: the case for combining cognitive-enhancing drugs with cognitive remediationPanayiota G Michalopoulou, Shôn W Lewis, Til Wykes, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 24, 2012
Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugsMichael J Peluso, Shôn W Lewis, Thomas R E Barnes, et al.
Schizophrenia Research|January 15, 2013
Non-neurological and metabolic side effects in the Cost Utility of the Latest Antipsychotics in Schizophrenia Randomised Controlled Trial (CUtLASS-1)Michael J Peluso, Shôn W Lewis, Thomas R E Barnes, et al.
Psychiatry Research|July 26, 2015
Patients' subjective rating of mental health improvement in a randomised controlled trialKaren P Hayhurst, Richard J Drake, Jennifer A Massie, et al.
Plos One|May 19, 2016
Correction: Therapist Effects and the Impact of Early Therapeutic Alliance on Symptomatic Outcome in Chronic Fatigue SyndromeLucy P Goldsmith, Graham Dunn, Richard P Bentall, et al.
Pageof 4